Literature DB >> 2015836

Restless legs syndrome and periodic leg movements in sleep: the primary role of dopaminergic mechanism.

J Montplaisir1, D Lorrain, R Godbout.   

Abstract

We report here the possible effect of opiates on a patient exhibiting particularly severe restless legs syndrome (RLS) and periodic leg movements in sleep (PLMS). This patient was investigated in the sleep laboratory under three conditions, namely, unmedicated (baseline), medicated with codeine sulfate, and medicated with both codeine sulfate and pimozide. Codeine sulfate dramatically improved abnormal motor behavior in this patient. The addition of pimozide reversed the beneficial effect of codeine during the Forced Immobilization Test but not in spontaneous RLS or PLMS at night. These results are discussed in view of the possible involvement of the dopaminergic mechanism in RLS/PLMS syndrome.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2015836     DOI: 10.1159/000116643

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  22 in total

Review 1.  Role of dopamine receptor agonists in the treatment of restless legs syndrome.

Authors:  Svenja Happe; Claudia Trenkwalder
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

2.  Iron deficiency anemia in infancy exerts long-term effects on the tibialis anterior motor activity during sleep in childhood.

Authors:  Patricio Peirano; Cecilia Algarin; Rodrigo Chamorro; Mauro Manconi; Betsy Lozoff; Raffaele Ferri
Journal:  Sleep Med       Date:  2012-07-04       Impact factor: 3.492

3.  Periodic limb movements in sleep exhibit a circadian rhythm that is maximal in the late evening/early night.

Authors:  Jeanne F Duffy; Alex S W Lowe; Edward J Silva; John W Winkelman
Journal:  Sleep Med       Date:  2010-11-18       Impact factor: 3.492

4.  Disconnection between periodic leg movements and cortical arousals in spinal cord injury.

Authors:  Aaro V Salminen; Mauro Manconi; Ville Rimpilä; Teemu M Luoto; Eerika Koskinen; Raffaele Ferri; Juha Ohman; Olli Polo
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

Review 5.  Control of sleep and wakefulness.

Authors:  Ritchie E Brown; Radhika Basheer; James T McKenna; Robert E Strecker; Robert W McCarley
Journal:  Physiol Rev       Date:  2012-07       Impact factor: 37.312

6.  Pergolide: treatment of choice in restless legs syndrome (RLS) and nocturnal myoclonus syndrome (NMS). A double-blind randomized crossover trial of pergolide versus L-Dopa.

Authors:  J Staedt; F Wassmuth; U Ziemann; G Hajak; E Rüther; G Stoppe
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

7.  Apomorphine in idiopathic restless legs syndrome: an exploratory study.

Authors:  G G Tribl; T Sycha; N Kotzailias; J Zeitlhofer; E Auff
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-02       Impact factor: 10.154

Review 8.  Gabapentin treatment in clozapine-induced restless legs syndrome: two cases and a review of the literature.

Authors:  Vijaya Kumar; Ganesan Venkatasubramanian
Journal:  Ther Adv Psychopharmacol       Date:  2016-10-12

Review 9.  Connectome and molecular pharmacological differences in the dopaminergic system in restless legs syndrome (RLS): plastic changes and neuroadaptations that may contribute to augmentation.

Authors:  Christopher J Earley; George R Uhl; Stefan Clemens; Sergi Ferré
Journal:  Sleep Med       Date:  2016-06-27       Impact factor: 3.492

10.  Periodic limb movements during sleep: population prevalence, clinical correlates, and racial differences.

Authors:  Holly Scofield; Thomas Roth; Christopher Drake
Journal:  Sleep       Date:  2008-09       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.